Navigation Links
Anti-Rat HRP-DAB Cell & Tissue Staining Kit from R&D Systems

ProductsAnti-Rat HRP-DAB Cell & Tissue Staining Kit from R&D Systems
Company R&D Systems
Item Anti-Rat HRP-DAB Cell & Tissue Staining Kit
Price $190.00
Description R&D Systems Cell and Tissue Staining Kits are intended for localization of antigens in a broad range of histological and cytological specimens. These kits may be used with primary IgG antibodies manufactured by either R&D Systems or by other vendors. Briefly, detection is based on the formation of the Avidin-Biotin Complex (ABC) with primary antibodies that reacted with tissue antigens under study. Visualization is based on enzymatic conversion of a chromogenic substrate 3,3 Diaminobenzidine (DAB) into a colored brown precipitate by horseradish peroxidase (HRP) at the sites of antigen localization, which can then be viewed using bright-field microscopy. The high detection sensitivity of R&D Systems staining kits is achieved by using high quality Secondary Biotinylated Antibodies and High Sensitivity Streptavidin conjugated to HRP (HSS-HRP). High Sensitivity Streptavidin is a chemical analog of Streptavidin that has little net positive charge at neutral or slightly alkaline pH and will interact only with biotin attached to secondary antibodies. HSS-HRP shows little or no non-specific binding to phospholipids, nucleic acids and carbohydrate binding proteins.

R&D Systems Cell and Tissue Staining Kits are manufactured to work equally well on cryostat and paraffin-embedded tissue sections, cytospin preparations (i.e. lymphocytes, monocytes, transfected cells) and free-floating tissue sections. The kits are made in a ready-to-use format including pre-diluted Secondary Biotinylated Antibodies and HSS-HRP that eliminates the need for extra steps in the procedure, minimizes hands-on time, maximizes convenience and reduces the risk of erroneous calculations.

  • Species: &nbnsp; Rat
Info R&D SystemsR&D Systems
R&D Systems, Inc.
614 McKinley Place N.E.
Minneapolis, MN 55413
Customer Service: 1 (800) 343-7475
1 (612) 379-2956

Fax Number: 1 (612) 656-4400
Web Site: http://www.rndsystems.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Anti-Rat HRP-AEC Cell & Tissue Staining Kit from R&D Systems
2. Rabbit Anti-Rat Neuromedin Antibody, Unconjugated from BACHEM
3. Goat Anti-Rat UGT1A7 (E-15) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
4. Mouse Anti-Rat L-Pyruvate Kinase Monoclonal Antibody, Unconjugated, Clone AD12 from ScheBo Biotech AG
5. Mouse Anti-Rat Pan-NMDA NR1 Monoclonal Antibody, Unconjugated, Clone R1JHL from Calbiochem
6. Mouse Anti-Rat Golgi Snap Receptor Complex Member 2 (GOSR2) Monoclonal Antibody, Unconjugated from Lifespan Biosciences
7. Rabbit Anti-Rat Potassium Channel Kv2.2 Antibody, Unconjugated from CHEMICON
8. Goat Anti-Rat CINC-2 alpha / beta Polyclonal Antibody, Unconjugated from R&D Systems
9. Rabbit Anti-Rat Synapsin I, phospho (Ser603) Monoclonal Antibody,, Clone PS603 from Invitrogen
10. Goat Anti-Rat CNTF R alpha Polyclonal Antibody, Unconjugated from R&D Systems
11. Mouse Anti-Rat WAVE 1 Monoclonal Antibody, Unconjugated, Clone 1.T.4 from Abcam
Sheep Anti-Staphylococcus DNase Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-zona radiata Monoclonal Antibody, Unconjugated, Clone MN-8C4 from Abcam
Rabbit Anti-KIAA1276 Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-Chk1, phospho (Ser296) Polyclonal Antibody, Unconjugated from Cell Signaling Technology
Biology Products:
(Date:11/20/2009)... Research Center (ERC) has been awarded a grant fr...methods of recovering and reusing the heat that wo...pression process in a carbon capture system. The g...n capture and sequestration, or storage (CCS), and... emitted into the atmosphere by coal-fired power p...
(Date:11/19/2009)...ists are revealing the genetic instructions inside... maize, has one of the most complex sequences of D...ison genomicist David Schwartz, who was one of mor...Science . , "The maize genome is a true maze fu...oubled would-be sequencers for years," says Schwar...
(Date:11/19/2009)...ov. 19 BIO-key Internati... wireless public safety and finger-based biometric...ial Shareholder Meeting held today was adjourned w... not present. ,, (Logo: http://www.newscom.com...impressive 99.3% of the 35 million votes cast vote...
Breaking Biology News(10 mins):Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 3Sweet corn story begins in UW-Madison lab 2Sweet corn story begins in UW-Madison lab 3BIO-key(R) Provides Update to Special Shareholder Meeting 2BIO-key(R) Provides Update to Special Shareholder Meeting 3Novartis drug Tasigna 28R 29 meets primary endpoint in pivotal trial against Gleevec 28R 29 as first line treatment in chronic myeloid leukemia patien 5579 1Novartis drug Tasigna 28R 29 meets primary endpoint in pivotal trial against Gleevec 28R 29 as first line treatment in chronic myeloid leukemia patien 5579 2Novartis drug Tasigna 28R 29 meets primary endpoint in pivotal trial against Gleevec 28R 29 as first line treatment in chronic myeloid leukemia patien 5579 3Novartis drug Tasigna 28R 29 meets primary endpoint in pivotal trial against Gleevec 28R 29 as first line treatment in chronic myeloid leukemia patien 5579 4Novartis drug Tasigna 28R 29 meets primary endpoint in pivotal trial against Gleevec 28R 29 as first line treatment in chronic myeloid leukemia patien 5579 5Novartis drug Tasigna 28R 29 meets primary endpoint in pivotal trial against Gleevec 28R 29 as first line treatment in chronic myeloid leukemia patien 5579 6Novartis drug Tasigna 28R 29 meets primary endpoint in pivotal trial against Gleevec 28R 29 as first line treatment in chronic myeloid leukemia patien 5579 7Novartis drug Tasigna 28R 29 meets primary endpoint in pivotal trial against Gleevec 28R 29 as first line treatment in chronic myeloid leukemia patien 5579 8Novartis drug Tasigna 28R 29 meets primary endpoint in pivotal trial against Gleevec 28R 29 as first line treatment in chronic myeloid leukemia patien 5579 9Novartis drug Tasigna 28R 29 meets primary endpoint in pivotal trial against Gleevec 28R 29 as first line treatment in chronic myeloid leukemia patien 5579 10Novartis drug Tasigna 28R 29 meets primary endpoint in pivotal trial against Gleevec 28R 29 as first line treatment in chronic myeloid leukemia patien 5579 11Novartis drug Tasigna 28R 29 meets primary endpoint in pivotal trial against Gleevec 28R 29 as first line treatment in chronic myeloid leukemia patien 5579 12Novartis drug Tasigna 28R 29 meets primary endpoint in pivotal trial against Gleevec 28R 29 as first line treatment in chronic myeloid leukemia patien 5579 13Novartis drug Tasigna 28R 29 meets primary endpoint in pivotal trial against Gleevec 28R 29 as first line treatment in chronic myeloid leukemia patien 5579 14Novartis drug Tasigna 28R 29 meets primary endpoint in pivotal trial against Gleevec 28R 29 as first line treatment in chronic myeloid leukemia patien 5579 15Judge Halts IHSS Home Care Cuts 3B Says They Likely Violate Federal Law 59781 1Judge Halts IHSS Home Care Cuts 3B Says They Likely Violate Federal Law 59781 2Checkered history of mother and daughter cells explains cell cycle differences 10424 1Checkered history of mother and daughter cells explains cell cycle differences 10424 2Checkered history of mother and daughter cells explains cell cycle differences 10424 3
... marine creatures in the vast, dark deep-sea surro...ming worms, crustaceans, and molluscs living in th...ion of ocean life. , Reporting this week in the jo... the deeper parts of the Southern Ocean - the sour...are likely to be related to animals living in both...
... potentially valuable organisms are at risk from s...de, says a new study led by a University of Toront...hide deposits near "black smokers"—undersea hydrot...ater into the frigid deep-sea environment, and sup...clam species—could smother and contaminate these c...
...and control yellow fever and dengue fever has beco...draft of the genome sequence of Aedes aegypti mosq...nstitute for Genomic Research (TIGR) and David Sev...is the complete set of genetic material including ... The research appears in the May 18, 2007 Science ...
Other Biology News:Scientists discover new life in the Antarctic deep sea 2Study warns deep-sea mining may pose serious threat to fragile marine ecosystems 2Study warns deep-sea mining may pose serious threat to fragile marine ecosystems 3Genome of yellow fever/dengue fever mosquito sequenced 2Genome of yellow fever/dengue fever mosquito sequenced 3
(Date:11/18/2009)...RNewswire/ -- Reportlinker.com announces that a ne...ogue. ,, Biotechnology Reagents - A Global Ma....com/p0164375/Biotechnology-Reagents---A-Global-Ma...m_medium=pr&utm_campaign=prnewswire ,, Re...compounds used in a range of biotech related areas...
(Date:11/18/2009)...rporation and SwitchGear Genomics announce a novel...s. , Madison, WI, USA (PR...SwitchGear Genomics announce a novel method for ch...a study using the HaloCHIP™ System and high-... to correlate DNA binding events to transcriptiona...
(Date:11/18/2009)...uces key cardiac enzymes at multiple time points a...eart Association 2009 Scientific Sessions , L...cs Inc., a biotechnology company pioneering the de...s derived from pathogens, today reported results f...Serp-1), an anti-inflammatory protein derived from...
(Date:11/18/2009)...Newswire-FirstCall/ -- Champions Biotechnology, I...development company with a predictive preclinical ... enhancing the value of oncology drugs, has establ...niversity and Southern Research Institute for the ...ientists from Yale and Southern Research found tha...
Breaking Biology Technology:Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 2Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 3Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 4Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 5Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 6Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 7Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 8Promega and SwitchGear Publish Findings from Combined Technologies that Correlate Binding Events and Transcriptional Activity 2Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 2Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 3Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 4Champions Biotechnology Enters into Licensing Agreement with Yale University and Southern Research Institute for the Repurposing of Bithionol for Oncology 2Champions Biotechnology Enters into Licensing Agreement with Yale University and Southern Research Institute for the Repurposing of Bithionol for Oncology 3Champions Biotechnology Enters into Licensing Agreement with Yale University and Southern Research Institute for the Repurposing of Bithionol for Oncology 4